About
Complement drug discovery
Areas of Focus
Categories
Biologics & BiopharmaceuticalChina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
191
By Phase
PHASE2: 3PHASE1: 1
By Status
NOT_YET_RECRUITING: 2ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05504187Lead Sponsor
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus
PHASE2Not yet recruiting
24 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2027
NCT05517980Lead Sponsor
Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
PHASE2Not yet recruiting
52 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2027
NCT05476887Lead Sponsor
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
PHASE2Active, not recruiting
35 participants
Started: Nov 25, 2022 · Completed: Feb 28, 2025
NCT05490017Lead Sponsor
To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104
PHASE1Completed
80 participants
Started: Dec 30, 2020 · Completed: Sep 2, 2022
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...